Thyrocare Technologies Limited — Others, 23-01-2025: ESOP/ESOS/ESPS

Thyrocare Technologies Limited has announced a board meeting to discuss key developments. The board approved the unaudited financial results for the quarter and nine months ended December 31, 2024, reporting a revenue of ₹152.55 Crore and a profit of ₹29.59 Crore. Additionally, Mr. Ramjee Dorai will retire as Company Secretary on January 31, 2025, and Mr. Brijesh Kumar has been appointed as his successor. The board also allotted 1,651 equity shares under the ESOS, increasing the paid-up share capital to ₹52.99 Crore. This update suggests a strong operational position, though the management's revision of depreciation estimates presents a notable accounting adjustment. Overall, investors may view these developments positively, with bolstered management and stable financial results.